(Reuters) - Canada announced new funding on Monday for clinical trials into an Ebola vaccine, and to create a stockpile of the vaccine and experimental treatments for use in the event the deadly disease reaches the country. Speaking at the laboratory in Winnipeg, Manitoba, where scientists developed an experimental Ebola treatment, ZMAb, Health Minister Rona Ambrose said Ottawa was committing C$23.5 million (12.96 million pounds) for research and development of Ebola vaccines and treatments. "These funds announced today will help support Ebola vaccine clinical trials and to create a stockpile of the vaccine and monoclonal antibody treatments of Ebola for use in Canada in the event of a case of Ebola, and to assist in the outbreak response in West Africa," Ambrose said. No cases of Ebola have been reported in Canada, but Ottawa announced on Friday it will stop issuing visas to people from the three West African nations where Ebola is widespread. Read More http://ift.tt/1DVMGOp
No comments:
Post a Comment